Swarajya

Our View
MagazineHeadlinesVideosस्वराज्यBooksEconomyCultureAdvertise
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economy
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • Weekend Issues Archive
  • News Brief
  • Subscriber login
  • Politics
  • Economy
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • Weekend Issues Archive
  • News Brief

COVAXIN

Bharat Biotech's Covaxin Is Safe, Generates Immune Response Against Covid-19: Lancet
Bharat Biotech's Covaxin Is Safe, Generates Immune Response Against Covid-19: LancetSwarajya StaffJan 22, 2021 07:06 AM
PM Modi Likely To Be Vaccinated In Second Phase Of Covid-19 Immunisation Drive In March-April: Report
PM Modi Likely To Be Vaccinated In Second Phase Of Covid-19 Immunisation Drive In March-April: ReportSwarajya StaffJan 21, 2021 07:30 AM
We Need A Dual  Strategy For Covid Vaccine – Market-Based Pricing For Those Who Can Afford It 
We Need A Dual Strategy For Covid Vaccine – Market-Based Pricing For Those Who Can Afford It R JagannathanJan 20, 2021 06:51 AM
Why There Will Never Be A Perfect Vaccine And Why We Should Trust What Our Scientists Developed
Why There Will Never Be A Perfect Vaccine And Why We Should Trust What Our Scientists Developed Venu Gopal NarayananJan 18, 2021 07:50 AM
Mild Infection After Covid-19 Vaccination Good Sign, Shows Immune System Responding To Vaccine: AIIMS Director
Mild Infection After Covid-19 Vaccination Good Sign, Shows Immune System Responding To Vaccine: AIIMS DirectorIANSJan 16, 2021 11:01 AM
PM Modi To Launch Pan India Roll Out Of COVID-19 Vaccination Drive Tomorrow
PM Modi To Launch Pan India Roll Out Of COVID-19 Vaccination Drive TomorrowSwarajya StaffJan 15, 2021 09:58 AM
Health Ministry Cautions Against Administering Covid-19 Vaccine To Pregnant, Lactating Women
Health Ministry Cautions Against Administering Covid-19 Vaccine To Pregnant, Lactating WomenSwarajya StaffJan 15, 2021 06:13 AM
Covaxin: Bharat Biotech Supplying 16.5 Lakh Doses Of Its Covid-19 Vaccine Free Of Cost To Government
Covaxin: Bharat Biotech Supplying 16.5 Lakh Doses Of Its Covid-19 Vaccine Free Of Cost To GovernmentSwarajya StaffJan 13, 2021 08:44 AM
Covid-19 Vaccination Drive To Kick Off In India On 16 January: Health Ministry
Covid-19 Vaccination Drive To Kick Off In India On 16 January: Health MinistryIANSJan 9, 2021 12:06 PM
'Vaccine Rajneeti' By Irresponsible Politicians Could Prove Costly For India
'Vaccine Rajneeti' By Irresponsible Politicians Could Prove Costly For IndiaArihant PawariyaJan 5, 2021 11:41 AM
Bharat Biotech Plans Covaxin Testing On Children As Young As Two Years; To Submit A Proposal To DCGI's Expert Panel Soon
Bharat Biotech Plans Covaxin Testing On Children As Young As Two Years; To Submit A Proposal To DCGI's Expert Panel SoonSwarajya StaffJan 5, 2021 06:08 AM
'Covaxin Is 200 Per Cent Safe': Bharat Biotech CMD Hits Out At Detractors Of Indian Covid-19 Vaccine
'Covaxin Is 200 Per Cent Safe': Bharat Biotech CMD Hits Out At Detractors Of Indian Covid-19 VaccineSwarajya StaffJan 4, 2021 02:44 PM
Indian Drug Regulator DCGI Approves Covid-19 Vaccines of AstraZeneca And Bharat Biotech
Indian Drug Regulator DCGI Approves Covid-19 Vaccines of AstraZeneca And Bharat Biotech Swarajya StaffJan 3, 2021 07:21 AM
Big Boost For India's Fight Against Covid-19: Serum Institute's Covishield, Bharat Biotech's Covaxin Granted Emergency Use Approval
Big Boost For India's Fight Against Covid-19: Serum Institute's Covishield, Bharat Biotech's Covaxin Granted Emergency Use ApprovalSwarajya StaffJan 3, 2021 06:14 AM
Boost To India's Fight Against Covid-19: Emergency Use Approval Recommended For SII's Covishield, Bharat Biotech's Covaxin
Boost To India's Fight Against Covid-19: Emergency Use Approval Recommended For SII's Covishield, Bharat Biotech's CovaxinSwarajya StaffJan 3, 2021 02:50 AM
Covaxin Can Deal With New Strains Of Coronavirus Too: Bharat Biotech
Covaxin Can Deal With New Strains Of Coronavirus Too: Bharat BiotechIANSDec 30, 2020 02:27 AM
COVAXIN: Bharat Biotech Again Applies For Emergency Use Approval Of Its Covid-19 Vaccine Candidate
COVAXIN: Bharat Biotech Again Applies For Emergency Use Approval Of Its Covid-19 Vaccine CandidateIANSDec 24, 2020 02:43 AM
Serum Institute Submits Additional Data Sought By India's Drug Regulator For Emergency Approval Of Covishield Vaccine
Serum Institute Submits Additional Data Sought By India's Drug Regulator For Emergency Approval Of Covishield VaccineIANSDec 23, 2020 02:50 AM
‘Made In India’ Covaxin’s Phase-1 Trial Results Are Out And They Are Promising
‘Made In India’ Covaxin’s Phase-1 Trial Results Are Out And They Are PromisingSwarajya StaffDec 18, 2020 11:54 AM
COVID-19: Bharat Biotech To Begin Phase-1 Trials Of Its Intranasal Vaccine Next Month
COVID-19: Bharat Biotech To Begin Phase-1 Trials Of Its Intranasal Vaccine Next MonthSwarajya StaffDec 9, 2020 10:15 AM
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype